Sort
10,766 grants matching “checkpoint inhibitor”
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$388,077Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2022 · CA
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$388,077Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$388,023Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2025 · CA
Project 4
$387,979Eva Hernando · New York University School Of Medicine · P50 · FY2025 · CA
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma
$387,868James Kim · Ut Southwestern Medical Center · R01 · FY2025 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$387,855Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2023 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$387,855Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2022 · CA
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
$387,785Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2019 · CA
Project 1: Targeting the PD-1 pathway in HCC
$387,766Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Project 2: Targeting STAT3 with an Oral Small Molecule to Treat HCC
$387,763David John Tweardy · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Individualized in situ vaccination by radiation and immunotherapy
$387,732Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$387,731Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2021 · CA
Individualized in situ vaccination by radiation and immunotherapy
$387,731Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$387,731Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2018 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$387,731Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$387,731Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Individualized in situ vaccination by radiation and immunotherapy
$387,731Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$387,731Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2022 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$387,731Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$387,727Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Immune Regulation of Lung Squamous Metastasis
$387,674Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Gene expression signature based screening in Ewing sarcoma
$387,507David J Gordon · University Of Iowa · R37 · FY2018 · CA